🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

4,760 results for “Pharm” Clear

  1. IW-3718

    IRONWOOD PHARMACEUTICALS INC

    Gastroesophageal Reflux Disease

    phase 2 small molecule completed

    1 trial

  2. IW-6118

    IRONWOOD PHARMACEUTICALS INC

    Healthy

    phase 2 small molecule completed

    1 trial

  3. IW-9179

    IRONWOOD PHARMACEUTICALS INC

    Dyspepsia

    phase 2 small molecule terminated

    1 trial

  4. IW-9179

    IRONWOOD PHARMACEUTICALS INC

    Diabetic Gastroparesis

    phase 2 small molecule completed

    1 trial

  5. Iberdomide, Iberdomide, Iberdomide, Iberdomide, Dexamethasone Tablets BP 2.0mg, Iberdomide, Iberdomide, Iberdomide, Dexamethasone 2mg Tablets , Iberdomide, Iberdomide, DARZALEX 1800 mg solution for injection, Iberdomide, Iberdomide, Iberdomide, Dexamethason-ratiopharm® 4 mg Tabletten

    Celgene Europe Limited

    Multiple Myeloma

    phase 2 small molecule active

    1 trial

  6. Ibezapolstat

    Acurx Pharmaceuticals

    Clostridium Difficile Infection Recurrence

    phase 2 small molecule active

    1 trial

  7. Ibezapolstat

    Acurx Pharmaceuticals

    Clostridium Difficile Infection

    phase 2 small molecule completed

    1 trial

  8. Ibrutinib

    Karyopharm Therapeutics Inc

    Lymphoma

    phase 2 small molecule active

    1 trial

  9. Ifetroban

    CUMBERLAND PHARMACEUTICALS INC

    Portal Hypertension

    phase 2 small molecule completed

    1 trial

  10. Ifetroban

    CUMBERLAND PHARMACEUTICALS INC

    Duchenne Muscular Dystrophy Cardiomyopathy

    phase 2 small molecule completed

    1 trial

  11. Ifetroban Injection

    CUMBERLAND PHARMACEUTICALS INC

    Hepatorenal Syndrome

    phase 2 small molecule completed

    1 trial

  12. Ifetroban Oral Capsule

    CUMBERLAND PHARMACEUTICALS INC

    Asthma, Aspirin-Induced

    phase 2 small molecule completed

    1 trial

  13. Ifetroban Sodium

    CUMBERLAND PHARMACEUTICALS INC

    Cardiovascular Diseases

    phase 2 small molecule completed

    1 trial

  14. Ifetroban Sodium

    CUMBERLAND PHARMACEUTICALS INC

    Idiopathic Pulmonary Fibrosis

    phase 2 small molecule active

    1 trial

  15. Ifetroban Sodium

    CUMBERLAND PHARMACEUTICALS INC

    Malignant Solid Tumor

    phase 2 small molecule active

    1 trial

  16. Ifetroban, Oral Capsule

    CUMBERLAND PHARMACEUTICALS INC

    Aspirin Exacerbated Respiratory Disease (AERD)

    phase 2 small molecule completed

    1 trial

  17. Ilofotase alfa, Ilofotase alfa Placebo Drug Product

    Lacuna Pharma Pty Ltd

    Risk for renal damage following open heart surgery

    phase 2 small molecule active

    1 trial

  18. Iloperidone

    Vanda Pharmaceuticals Netherlands B.V.

    Parkinson Disease Psychosis

    phase 2 small molecule terminated

    1 trial

  19. Iloperidone crystalline formulation

    Vanda Pharmaceuticals Netherlands B.V.

    Schizophrenia

    phase 2 small molecule completed

    1 trial

  20. Imdusiran

    Arbutus Biopharma Corp

    Hepatitis B, Chronic

    phase 2 small molecule terminated

    1 trial

  21. Imdusiran (AB-729)

    Arbutus Biopharma Corp

    Chronic Hepatitis B

    phase 2 small molecule active

    1 trial

  22. Imdusiran, IMFINZI 50 mg/mL concentrate for solution for infusion.

    Arbutus Biopharma Corp

    Chronic HBV Infection

    phase 2 small molecule active

    1 trial

  23. Imgatuzumab

    Centessa Pharmaceuticals plc

    Cutaneous Squamous Cell Carcinoma

    phase 2 small molecule terminated

    1 trial

  24. Imnovid 4 mg hard capsules, JAMP Pomalidomide, Pomalidomide Adalvo 3 mg hard capsules, Imnovid 1 mg hard capsules, Imnovid 4 mg hard capsules, Pomalidomide Adalvo 1 mg hard capsules, Imnovid 2 mg hard capsules, JAMP Pomalidomide, Imnovid 1 mg hard capsules, JAMP Pomalidomide, Dexamethason 4 mg JENAPHARM®, Imnovid 3 mg hard capsules, Pomalidomide Adalvo 4 mg hard capsules, Pomalidomide Adalvo 2 mg hard capsules, Dexamethason 8 mg JENAPHARM®, Isatuximab, Isatuximab, JAMP Pomalidomide, Imnovid 3 mg hard capsul

    Sanofi-aventis Healthcare Pty Ltd

    Cancer

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources